<DOC>
	<DOCNO>NCT01070043</DOCNO>
	<brief_summary>The purpose study assess efficacy safety fix dose combination 5 mg amlodipine/80 mg valsartan compare 160 mg valsartan monotherapy lower blood pressure Taiwanese patient .</brief_summary>
	<brief_title>To Demonstrate Non-inferiority Combination 5 mg Amlodipine/ 80 mg Valsartan 160 mg Valsartan Alone</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Participants 18 year age hypertension define sit systolic blood pressure 140 mmHg 180 mmHg sit diastolic blood pressure 90 mmHg 120 mmHg . High risk participant ( define : ( diabetes mellitus , chronic renal disease , Framingham 10year risk score &gt; 10 % , establish coronary artery disease ( CAD ) , CAD equivalents include carotid artery disease , peripheral arterial disease ( PAD ) , abdominal aortic aneurysm ( AAA ) ) hypertension define sit systolic blood pressure 130 mmHg 180 mmHg sit diastolic blood pressure 80 mmHg 120 mmHg . Known suspected secondary hypertension Known New York Heart Association ( NYHA ) functional class IV Heart Failure History myocardial infarction , transient ischemic attack cerebrovascular accident within precede 3 month Clinically significant valvular disease Women pregnant , intend become pregnant breastfeeding Participants severe medical condition ( ) view Investigator prohibit participation study Participants hypersensitivity investigational/ reference drug component formulation . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>valsartan</keyword>
	<keyword>amlodipine</keyword>
	<keyword>high blood pressure</keyword>
</DOC>